| Dexamethasone (n = 102) | Prednisone (n = 94) | Total (n = 196) | OR | 95% CI | P-value | |||
| n | % | n | % | n | % |
|
|
|
Induction treatment |
|
|
|
|
|
|
|
|
|
Complete remission | 71 | 69.6 | 71 | 75.5 | 142 | 72.4 |
|
|
|
Induction failures | 31 | 30.4 | 23 | 24.5 | 54 | 27.6 | 0.74 | 0.39 - 1.40a | 0.351 |
Abandonment | 12 | 11.7 | 11 | 11.7 | 23 | 11.7 | 0.92 | 0.38 - 2.21a | 0.851 |
Death | 14 | 13.7 | 8 | 8.5 | 22 | 11.3 | 0.57 | 0.23 - 1.45a | 0.231 |
Resistant disease | 5 | 4.9 | 4 | 4.3 | 9 | 4.6 | 0.80 | 0.21 - 3.10a | 1.002 |
Overall events |
|
|
|
|
|
|
|
|
|
Continuous CR | 45 | 44.1 | 45 | 47.9 | 90 | 45.9 |
|
|
|
Treatment failures | 57 | 55.9 | 49 | 52.1 | 106 | 54.1 | 0.86 | 0.49 - 1.51b | 0.601 |
Abandonment | 25 | 24.5 | 24 | 25.5 | 49 | 25.0 | 0.96 | 0.48 - 1.93b | 0.911 |
Death | 18 | 17.7 | 14 | 14.9 | 32 | 16.3 | 0.78 | 0.34 - 1.75b | 0.541 |
Leukemic event | 14 | 13.7 | 11 | 11.7 | 25 | 12.8 | 0.79 | 0.32 - 1.92b | 0.591 |